TFMFly, or TFM-FLY, also known as DOTFM-FLY, is a serotonin receptor modulator of the phenethylamine, amphetamine and DOx, and FLY families related to psychedelics like DOTFM and DOB-FLY.
Pharmacology
Pharmacodynamics It acts as a potent agonist at the 5HT2A serotonin receptor subtype, and is a chiral compound with the more active (R) enantiomer having a Ki of 0.12 nM at the human 5-HT2A receptor. While the fully aromatic benzodifurans such as Bromo-DragonFLY generally have higher binding affinity than saturated compounds like 2C-B-FLY, the saturated compounds have higher efficacy as agonists.
Chemistry
Synthesis The chemical synthesis of TFMFly has been described.
Analogues Analogues of TFMFly include DOTFM, DOB-FLY, and 25TFM-NBOMe, among others.
History TFMFly was first reported by a team at Purdue University led by David E. Nichols in 2001.
Society and culture
Legal status
Latvia TFMFly is illegal in Latvia.
See also FLY (psychedelics)
References
External links TFM-FLY - Isomer Design


